// App-Quantinova.ai

2126 : Impact of Risankizumab on Enthesitis and Dactylitis: Integrated Analysis of the Phase 3, Randomized, Double-Blind KEEPsAKE 1 and 2 Trials

Researchers

Presenter

  • Dennis McGonagle

Principal Investigators

  • Shawn Kwatra

  • Saakshi Khattri

  • Ahmad Amin

  • Huzefa Photowala

  • Ran Liu

  • Byron Padilla

  • Blair Kaplan

Medical Centers

  • Northwestern Medicine Dermatology, Chicago, IL

  • Johns Hopkins University, Baltimore, MD

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Mount Sinai Medical Center, New York, NY

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Dactylitis

Biomarkers

  • N/A

Drug/Treatment

  • Risankizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Open Label

Phase

  • III

Study Id's

  • NCT03675308

  • NCT03671148

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved